Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells

Cytokine
Shin-Young ParkJoong-Soo Han

Abstract

Lipopolysaccharide (LPS) has been known to produce inflammatory modulators such as tumor necrosis factor alpha (TNF-alpha) or nitric oxide (NO). In this study, we examined the effects of nicotine on LPS enhanced NO synthesis and inducible nitric oxide synthase (iNOS) expression in macrophages. LPS-induced NO synthesis and iNOS expression were significantly decreased by nicotine. To investigate the signaling mechanism of nicotine induced suppression of NO synthesis and iNOS expression induced by LPS, we focused on the possible roles of p42/44 MAPK, S6K1, and signal transducers and activators of transcription 3 (STAT3) signaling. LPS is known to activate p42/44 MAPK and S6K1, which in turn activates STAT3 to induce inflammatory regulators. Pretreatment of cells with nicotine blocked LPS-induced p42/44 MAPK and S6K1 as well as iNOS promoter activity. Furthermore, we found that LPS-induced phosphorylation of STAT3 at serine 727 is mediated by S6K1-p42/44 MAPK pathway, and this STAT3 phosphorylation was also blocked by nicotine. We also found that downregulation of STAT3 using STAT3 siRNA resulted in suppression of the NO synthesis and iNOS expression. Taken together, our results suggest that nicotine inhibits LPS-induced NO synthes...Continue Reading

References

Oct 5, 1995·Nature·E J BrownS L Schreiber
Dec 1, 1995·Journal of Periodontology·M J PabstJ P Babu
Mar 11, 1999·Current Opinion in Genetics & Development·P B DennisG Thomas
Mar 10, 2001·Nature·L Chang, M Karin
Mar 21, 2001·Cellular Signalling·M Guha, N Mackman
Jul 11, 2001·Immunologic Research·J Hawiger
Jul 21, 2001·The Biochemical Journal·W K AldertonR G Knowles
Aug 9, 2002·The European Respiratory Journal·M M Monick, G W Hunninghake
Nov 5, 2002·Clinical and Diagnostic Laboratory Immunology·Melanie J ScottWilliam G Cheadle
Mar 27, 2004·Journal of Dental Research·F Di Nardo Di MaioM Felaco
Apr 2, 2004·Journal of Neurochemistry·R Douglas ShytleJun Tan
Aug 17, 2005·Current Drug Targets. Inflammation and Allergy·Riku KorhonenEeva Moilanen
Sep 6, 2007·Molecular and Cellular Biochemistry·Derek BoyerKay K Lee-Fruman
Nov 13, 2007·Nature Immunology·Jason S StumhoferChristopher A Hunter

❮ Previous
Next ❯

Citations

Nov 19, 2010·Antioxidants & Redox Signaling·Astrid SprussIna Bergheim
Apr 12, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Frédéric LallemandPaul Verbanck
Jun 22, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Qi LiJuliy M Perelman
Oct 22, 2009·American Journal of Respiratory Cell and Molecular Biology·Chun K WongChristopher W K Lam
Aug 2, 2011·Journal of Neuroinflammation·Ingo SchulzHans-Ulrich Demuth
Feb 6, 2013·PloS One·Daniel ParisMichael J Mullan
Jul 4, 2012·The Journal of Nutritional Biochemistry·Sabine WagnerbergerIna Bergheim
Nov 17, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Qi LiJuliy M Perelman
Jan 23, 2013·The Journal of Pathology·Haifeng ZhuHesham M Amin
May 20, 2015·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jing WuKatherine Cianflone
Jun 4, 2014·International Immunopharmacology·Shiby Kuriakose, Jude E Uzonna
Nov 28, 2012·European Journal of Pharmacology·Daniel ParisMichael Mullan
Jun 16, 2014·European Journal of Nutrition·Giridhar KanuriIna Bergheim
Nov 6, 2014·Experimental and Therapeutic Medicine·Aihong MengYuna Shi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here